EBS

Emergent Biosolutions (EBS)

About Emergent Biosolutions (EBS)

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Details

Daily high
$8.35
Daily low
$7.70
Price at open
$7.78
52 Week High
$15.10
52 Week Low
$1.42
Market cap
438.9M
Dividend yield
0.00%
Volume
2.5M
Avg. volume
1.0M
P/E ratio
-1.98

Emergent Biosolutions News

Details

Daily high
$8.35
Daily low
$7.70
Price at open
$7.78
52 Week High
$15.10
52 Week Low
$1.42
Market cap
438.9M
Dividend yield
0.00%
Volume
2.5M
Avg. volume
1.0M
P/E ratio
-1.98